Follow
Daniel L Hertz
Title
Cited by
Cited by
Year
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update
CL Loprinzi, C Lacchetti, J Bleeker, G Cavaletti, C Chauhan, DL Hertz, ...
ASCO, 2020
5622020
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and …
KE Caudle, K Sangkuhl, M Whirl‐Carrillo, JJ Swen, CE Haidar, TE Klein, ...
Clinical and translational science 13 (1), 116-124, 2020
4222020
Vincristine-induced peripheral neuropathy in pediatric cancer patients
E Mora, EML Smith, C Donohoe, DL Hertz
American journal of cancer research 6 (11), 2416, 2016
1762016
CYP2C8* 3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
DL Hertz, S Roy, AA Motsinger-Reif, A Drobish, LS Clark, HL McLeod, ...
Annals of oncology 24 (6), 1472-1478, 2013
1192013
CYP2C8* 3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
DL Hertz, AA Motsinger-Reif, A Drobish, SJ Winham, HL McLeod, ...
Breast cancer research and treatment 134, 401-410, 2012
1142012
Tamoxifen and CYP2D6: a contradiction of data
DL Hertz, HL McLeod, WJ Irvin Jr
The oncologist 17 (5), 620-630, 2012
892012
Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer
ME Dolan, O El Charif, HE Wheeler, ER Gamazon, ...
Clinical Cancer Research 23 (19), 5757-5768, 2017
752017
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
A Chan, DL Hertz, M Morales, EJ Adams, S Gordon, CJ Tan, NP Staff, ...
Supportive care in cancer 27, 3729-3737, 2019
672019
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients …
DL Hertz, MV Caram, KM Kidwell, JN Thibert, C Gersch, NJ Seewald, ...
Pharmacogenomics 17 (3), 231-240, 2016
672016
Pharmacogenetics of cancer drugs
DL Hertz, J Rae
Annual Review of Medicine 66, 65-81, 2015
642015
Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity
DL Hertz, HL McLeod
Journal of human genetics 58 (6), 346-352, 2013
612013
Tamoxifen dose escalation in patients with diminished CYP2D6 activity normalizes endoxifen concentrations without increasing toxicity
DL Hertz, A Deal, JG Ibrahim, CM Walko, KE Weck, S Anderson, ...
The oncologist 21 (7), 795-803, 2016
572016
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy
DL Hertz, K Owzar, S Lessans, C Wing, C Jiang, WK Kelly, J Patel, ...
Clinical Cancer Research 22 (19), 4890-4900, 2016
552016
Genetic heterogeneity beyond CYP2C8* 3 does not explain differential sensitivity to paclitaxel-induced neuropathy
DL Hertz, S Roy, J Jack, AA Motsinger-Reif, A Drobish, LS Clark, ...
Breast cancer research and treatment 145, 245-254, 2014
512014
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
DL Hertz, AC Snavely, HL McLeod, CM Walko, JG Ibrahim, S Anderson, ...
British journal of clinical pharmacology 80 (5), 1122-1130, 2015
502015
Paclitaxel plasma concentration after the first infusion predicts treatment-limiting peripheral neuropathy
DL Hertz, KM Kidwell, K Vangipuram, F Li, MP Pai, M Burness, JJ Griggs, ...
Clinical Cancer Research 24 (15), 3602-3610, 2018
492018
Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study
TM Salgado, CS Quinn, EK Krumbach, I Wenceslao, M Gonzalez, ...
Supportive Care in Cancer 28, 4163-4172, 2020
432020
Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy
SD Krens, HL McLeod, DL Hertz
Pharmacogenomics 14 (5), 555-574, 2013
402013
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
Y Sun, JH Kim, K Vangipuram, DF Hayes, EML Smith, L Yeomans, ...
Breast cancer research and treatment 171, 657-666, 2018
382018
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity
TP Ahern, DL Hertz, P Damkier, B Ejlertsen, SJ Hamilton-Dutoit, JM Rae, ...
American journal of epidemiology 185 (2), 75-85, 2017
382017
The system can't perform the operation now. Try again later.
Articles 1–20